Page 4 - Paolo Tarantino News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Dr Tarantino on the Use of ADCs in HR+ Breast Cancer

Paolo Tarantino, MD, discusses the use of antibody drug conjugates in patients with hormone receptor-positive breast cancer.

Paolo tarantinoEuropean institute of oncologyDana farber cancer instituteEuropean instituteScience summitBreast cancerOnclive tv

Dr Tarantino on Patient Awareness of the Platinum Shortage in Breast Cancer

Dr Tarantino on Patient Awareness of the Platinum Shortage in Breast Cancer
onclive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from onclive.com Daily Mail and Mail on Sunday newspapers.

United statesPaolo tarantinoEuropean institute of oncologyNational comprehensive cancer networkDana farber cancer instituteEuropean institute

Dr Tarantino on the Effects of Platinum Chemotherapy Shortages in Breast Cancer

Dr Tarantino on the Effects of Platinum Chemotherapy Shortages in Breast Cancer
onclive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from onclive.com Daily Mail and Mail on Sunday newspapers.

United statesPaolo tarantinoNational comprehensive cancer networkDana farber cancer instituteEuropean institute of oncologyEuropean institute

Dr Tarantino on the Impact of Emerging ADCs in HR+ Breast Cancer

Dr Tarantino on the Impact of Emerging ADCs in HR+ Breast Cancer
onclive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from onclive.com Daily Mail and Mail on Sunday newspapers.

Paolo tarantinoDana farber cancer instituteEuropean institute of oncologyEuropean institute

Expanding Definitions of HER2 Expression Mediate the Role of ADCs in Breast Cancer

Erika P. Hamilton, MD, discusses the role of trastuzumab deruxtecan in HER2-positive and HER2-low breast cancer; the evolution of CDK4/6 inhibitors in hormone receptor–positive disease; and how genetic testing can match patients with personalized therapies and support further precision medicine research.

United statesDana farber cancer instituteAndrew mckenzieHowarda burrisPaolo tarantinoIan kropDenise yardleySarah cannon research instituteScience summitBreast cancerGynecologic cancer researchPatients with her2 positive breast cancerErikap hamiltonTrastuzumab deruxtecanPatritumab deruxtecanDestiny breast09 trial